Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 5, Pages 1280
Publisher
MDPI AG
Online
2021-02-27
DOI
10.3390/molecules26051280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High cholesterol induces apoptosis and autophagy through the ROS-activated AKT/FOXO1 pathway in tendon-derived stem cells
- (2020) Kaiqun Li et al. Stem Cell Research & Therapy
- Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
- (2020) Skylar T. Chuang et al. Nanomaterials
- Mitotic Poisons in Research and Medicine
- (2020) Jan Škubník et al. MOLECULES
- Endoplasmic reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma
- (2019) Zichao Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
- (2019) Meng Lei et al. DRUG DELIVERY
- Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment
- (2019) Ying Li et al. MOLECULAR PHARMACEUTICS
- Identifying and targeting angiogenesis-related microRNAs in ovarian cancer
- (2019) Xiuhui Chen et al. ONCOGENE
- Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression
- (2019) Cuiping Jiang et al. JOURNAL OF CONTROLLED RELEASE
- A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
- (2018) Min Li et al. Acta Biomaterialia
- Hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice
- (2018) Yanping Qian et al. ACS Applied Materials & Interfaces
- Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications for in vivo applications
- (2018) Sean F. Gilmore et al. Nanoscale
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
- (2018) Sangram Raut et al. Frontiers in Pharmacology
- Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
- (2017) Yu Mima et al. JOURNAL OF CONTROLLED RELEASE
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
- (2017) András Füredi et al. JOURNAL OF CONTROLLED RELEASE
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells
- (2016) Fangrong Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Mechanistic diversity in ATP-binding cassette (ABC) transporters
- (2016) Kaspar P Locher NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mechanistic diversity in ATP-binding cassette (ABC) transporters
- (2016) Kaspar P Locher NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery
- (2015) Jijin Gu et al. BIOMATERIALS
- Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment
- (2015) Assogba G. Assanhou et al. BIOMATERIALS
- A Biomimic Reconstituted High-Density-Lipoprotein-Based Drug and p53 Gene Co-delivery System for Effective Antiangiogenesis Therapy of Bladder Cancer
- (2015) Qiaohong Ouyang et al. Nanoscale Research Letters
- A Biomimic Reconstituted High-Density-Lipoprotein-Based Drug and p53 Gene Co-delivery System for Effective Antiangiogenesis Therapy of Bladder Cancer
- (2015) Qiaohong Ouyang et al. Nanoscale Research Letters
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Combination of Apolipoprotein A1-Modi Liposome–Doxorubicin with Autophagy Inhibitors Overcame Drug Resistance In Vitro
- (2014) Baolong Wang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier
- (2013) Yuan Yuan et al. JOURNAL OF DRUG TARGETING
- Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells
- (2013) Yubin Li et al. MOLECULAR NEUROBIOLOGY
- In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells
- (2008) Ken-ichi Ogawara et al. JOURNAL OF CONTROLLED RELEASE
- Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
- (2007) Tatsuhiro Ishida et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now